<p>Adoptive T cell therapy (ACT) using ex vivo–expanded autologous tumor-infiltrating lymphocytes (TILs) can mediate complete regression of certain human cancers. The impact of TIL phenotypes on clinical success of TIL-ACT is currently unclear. Samples were analyzed from TIL infusion products from metastatic melanoma human patients who responded to TIL-ACT (responders) and patients who did not (non-responders). Single cell transcriptome of TIL infusion products were analyzed for CD8 TIL phenotype and function. In patients with available neoantigen reactive TIL, single cell TCR clonotyping was performed to study anti-tumor TIL states between responders and non-responders. Epigenetic studies on TIL infusion products were performed using ATAC sequencing between paired CD39- C69- and CD39+ CD69+ CD8+ TILs.</p>

Transcriptome and Epigenome of TIL Infusion for Cancer Immunotherapy

1 selected publication including "Stem-like CD8 T cells mediate response of adoptive cell immunotherapy ..." (425 citations)

Transcriptome and Epigenome of TIL Infusion for Cancer Immunotherapy

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer